Last updated 2026-07-20
- Raised $4M Seed round, Jun 2020
Total raised
$4.0M
Last: Undisclosed Round 2020-07
Stage
Seed
Founded
2020
Headcount
6
HQ
Netanya, Israel
Sector
Health Tech & Life Sciences
About
EARLY Labs is an innovative Biotech company, operating in the field of Volatile Organic Compound based diagnostics. The company is developing a revolutionary multi-cancer test platform, currently focusing on lung cancer, detecting lung cancer in urine samples, from its earliest stages – with groundbreaking 90% stage I sensitivity and specificity results. By Q4 2024 the platform will be calibrated to run Colon testing as well, and other cancer types to follow. Simplicity of the test, which can be done at home or at pharmacies, using a urine collection kit, is expected to break existing uptake barriers such as invasiveness, radiation, long waiting lists, inconvenience and more, and completely change the cancer screening paradigm.
Funding history · 1 round · $4.0M total
2020-06
Seed
$4.0M
Headcount over time
From 4 (2023-02) to 6 (2026-03) · +2 (+50%) · 8 points · source: Finder history + radar grounding
Q&A
- What is EARLY Labs' primary focus in cancer screening?
- EARLY Labs is developing a multi-cancer test platform, currently focusing on detecting lung cancer in urine samples with 90% stage I sensitivity and specificity results.
- What is the expected future development for EARLY Labs' screening platform?
- By Q4 2024, EARLY Labs plans to calibrate its platform to run colon cancer testing, with other cancer types to follow.
- What is the total funding raised by EARLY Labs to date?
- EARLY Labs has raised a total of $4,000,000.
- When was EARLY Labs founded?
- EARLY Labs was founded in July 2020.
- What is the current employee count for EARLY Labs?
- EARLY Labs has 1-10 employees.
- What is the primary sector of EARLY Labs?
- EARLY Labs operates in the Health Tech & Life Sciences sector.
- What technologies does EARLY Labs utilize in its platform?
- EARLY Labs utilizes Artificial Intelligence, Machine Learning, Biologicals, Molecules, Sensing, and Scent technologies.
- What is the current product stage of EARLY Labs?
- EARLY Labs' product is in the clinical trial stage.
Team · 1
Michal Mark Danieli
Founder · Founder & CEO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyTest Diagnostics & Screening
Technologies
Artificial IntelligenceMachine LearningBiologicalsMoleculesSensingScent
Target customers
Healthcare & Life SciencesHealthcareProvidersPatients
Business model
B2B2C
Highlights
1 PatentsVerified
Tags
early-detectioncancer-diagnosticsmedical-technologiesscreeningbiomarkerscancer-researchdiagnosticscancerpulmonarymachine-learningbiosensorsbiotechnology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | earlylabs.io |
|---|---|
| linkedin.com/company/90826275 |
Identifiers & details
| Founded | 2020-7 |
|---|---|
| Employees (exact) | 6 |
Radar intelligence
Web history (Wayback)
| Domain | earlylabs.io |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516207065 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2020-06-14 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 4 — annual_report (3), violation (1) |
| Registered address | מאיר אריאל 4 נתניה |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-30 | דו~ח שנתי-הוספת בעל תפקיד |
| 2026-06-30 | דו~ח שנתי-עדכון מען דיגיטלי |
| 2026-06-30 | דו~ח שנתי-עדכון בעלי מניות |
| 2026-06-30 | עדכון הפרה |